LAB
Standard BioTools Inc. (LAB) PESTLE Analysis Analysis (2026)
Overall Score
Political
No material political catalysts or regulatory developments were provided this month.
Economic
The company continues to trade at a low valuation with EV/Sales of 0.44 and Price/Sales of 3.30, but profitability remains deeply negative with net margin at -103.3%.
Liquidity remains very strong with a current ratio of 9.10 and quick ratio of 8.80, which helps offset weak operating performance.
Social
No new social or customer-demand developments were provided this month.
Technological
No material technology, product, or R&D developments were provided this month.
Legal
No new litigation, compliance, or legal developments were provided this month.
Environmental
No material environmental or sustainability developments were provided this month.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Standard BioTools Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.